(1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate

C26H24N6O4S — CID 53295000

IUPAC(1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate
SMILESO=C1/C(=C\C=C\c2ccccc2)N=C(SC/C([O-])=N\c2c[n+](N3CCOCC3)no2)N1c1ccccc1
InChIInChI=1S/C26H24N6O4S/c33-23(28-24-18-31(29-36-24)30-14-16-35-17-15-30)19-37-26-27-22(13-7-10-20-8-3-1-4-9-20)25(34)32(26)21-11-5-2-6-12-21/h1-13,18H,14-17,19H2/b10-7+,22-13+
InChIKeyNGJBVAQABRTSKO-QNUVFLEMSA-N
MW516.58 g/mol
LogP2.05
Rot. Bonds7

About (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate

(1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate (PubChem CID 53295000) has the molecular formula C26H24N6O4S and a molecular weight of 516.58 g/mol. Its IUPAC name is (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate.

Molecular Properties

Compound Name(1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate
PubChem CID53295000
Molecular FormulaC26H24N6O4S
Molecular Weight516.58 g/mol
Exact Mass516.16
IUPAC Name(1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate
SMILESO=C1/C(=C\C=C\c2ccccc2)N=C(SC/C([O-])=N\c2c[n+](N3CCOCC3)no2)N1c1ccccc1
InChIInChI=1S/C26H24N6O4S/c33-23(28-24-18-31(29-36-24)30-14-16-35-17-15-30)19-37-26-27-22(13-7-10-20-8-3-1-4-9-20)25(34)32(26)21-11-5-2-6-12-21/h1-13,18H,14-17,19H2/b10-7+,22-13+
InChIKeyNGJBVAQABRTSKO-QNUVFLEMSA-N
XLogP2.05
TPSA110.47 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500516.58
LogP ≤ 52.05
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate?
The IUPAC name of (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate (CID 53295000) is (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate.
What is the SMILES notation for (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate?
The canonical SMILES for (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate is O=C1/C(=C\C=C\c2ccccc2)N=C(SC/C([O-])=N\c2c[n+](N3CCOCC3)no2)N1c1ccccc1.
What is the InChIKey of (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate?
The InChIKey is NGJBVAQABRTSKO-QNUVFLEMSA-N. The full InChI is InChI=1S/C26H24N6O4S/c33-23(28-24-18-31(29-36-24)30-14-16-35-17-15-30)19-37-26-27-22(13-7-10-20-8-3-1-4-9-20)25(34)32(26)21-11-5-2-6-12-21/h1-13,18H,14-17,19H2/b10-7+,22-13+.
What are the key properties of (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate?
(1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate has a molecular weight of 516.58 g/mol, XLogP of 2.05, 7 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (1E)-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(E)-3-phenylprop-2-enylidene]imidazol-2-yl]sulfanylethanimidate is sourced from PubChem (CID 53295000), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).